Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

932 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Control of backbone chemistry and chirality boost oligonucleotide splice switching activity.
Kandasamy P, McClorey G, Shimizu M, Kothari N, Alam R, Iwamoto N, Kumarasamy J, Bommineni GR, Bezigian A, Chivatakarn O, Butler DCD, Byrne M, Chwalenia K, Davies KE, Desai J, Shelke JD, Durbin AF, Ellerington R, Edwards B, Godfrey J, Hoss A, Liu F, Longo K, Lu G, Marappan S, Oieni J, Paik IH, Estabrook EP, Shivalila C, Tischbein M, Kawamoto T, Rinaldi C, Rajão-Saraiva J, Tripathi S, Yang H, Yin Y, Zhao X, Zhou C, Zhang J, Apponi L, Wood MJA, Vargeese C. Kandasamy P, et al. Among authors: desai j. Nucleic Acids Res. 2022 Jun 10;50(10):5443-5466. doi: 10.1093/nar/gkac018. Nucleic Acids Res. 2022. PMID: 35061895 Free PMC article.
Predicting exon criticality from protein sequence.
Desai J, Francis C, Longo K, Hoss A. Desai J, et al. Nucleic Acids Res. 2022 Apr 8;50(6):3128-3141. doi: 10.1093/nar/gkac155. Nucleic Acids Res. 2022. PMID: 35286381 Free PMC article.
Impact of stereopure chimeric backbone chemistries on the potency and durability of gene silencing by RNA interference.
Liu W, Iwamoto N, Marappan S, Luu K, Tripathi S, Purcell-Estabrook E, Shelke JD, Shah H, Lamattina A, Pan Q, Schrand B, Favaloro F, Bedekar M, Chatterjee A, Desai J, Kawamoto T, Lu G, Metterville J, Samaraweera M, Prakasha PS, Yang H, Yin Y, Yu H, Giangrande PH, Byrne M, Kandasamy P, Vargeese C. Liu W, et al. Among authors: desai j. Nucleic Acids Res. 2023 May 22;51(9):4126-4147. doi: 10.1093/nar/gkad268. Nucleic Acids Res. 2023. PMID: 37070173 Free PMC article.
A phase II trial of larotrectinib in tumors with NTRK fusions or extremes of NTRK mRNA overexpression identified by comprehensive genomic profiling.
Thavaneswaran S, Sim HW, Grady J, Espinoza D, Huang ML, Lin F, McGrath M, Desai J, Charakidis M, Brown M, Kansara M, Simes J, Thomas D. Thavaneswaran S, et al. Among authors: desai j. Oncologist. 2024 Dec 25:oyae339. doi: 10.1093/oncolo/oyae339. Online ahead of print. Oncologist. 2024. PMID: 39720993 Free article.
Correction: International Alliance of Urolithiasis (IAU) consensus on miniaturized percutaneous nephrolithotomy.
Zeng GH, Zhong W, Mazzon G, Zhu W, Lahme S, Khadgi S, Desai J, Agrawal M, Schulsinger D, Gupta M, Montanari E, Martinez JML, Almousawi S, Malonzo VEF, Sriprasad S, Durutovic O, Arumuham V, Ferretti S, Kamal W, Xu KW, Cheng F, Gao XF, Cheng JW, Somani B, Duvdevani M, Git KA, Seitz C, Bernardo N, Ibrahim TAA, Aquino A, Yasui T, Fiori C, Knoll T, Papatsoris A, Gadzhiev N, Zhanbyrbekuly U, Angerri O, Ramos HL, Saltirov I, Moussa M, Giusti G, Vicentini F, Suarez EB, Pearle M, Preminger GM, Wu QH, Chai CA, Ghani K, Maroccolo M, Brehmer M, Osther PJ, Zawadzki M, Tursunkulov A, Kytaibekovich MN, Abuvohidov AA, Lara CAR, Noori Z, Zanetti SP, Shrestha S, de la Rosette J, Denstedt J, Ye ZQ, Sarica K, Choong S. Zeng GH, et al. Among authors: desai j. Mil Med Res. 2024 Dec 16;11(1):79. doi: 10.1186/s40779-024-00579-8. Mil Med Res. 2024. PMID: 39676164 Free PMC article. No abstract available.
The 5-factor modified frailty index as a prognostic factor following stereotactic radiosurgery for metastatic disease to the brain from non-small cell lung cancer: A multi-center cohort analysis.
Rajkumar S, Kite T, Desai J, Lucido T, Mathieu D, Tripathi M, Singh N, Kumar N, Mantziaris G, Pikis S, Sheehan JP, Wegner RE, Shepard MJ. Rajkumar S, et al. Among authors: desai j. J Clin Neurosci. 2024 Dec 13;132:110979. doi: 10.1016/j.jocn.2024.110979. Online ahead of print. J Clin Neurosci. 2024. PMID: 39673841
Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined With Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies.
Luke JJ, Gelmon K, Siu LL, Moreno V, Desai J, Gomez-Roca CA, Carlino MS, Pachynski RK, Cosman R, Chu QS, Damian S, Curigliano G, Tam R, Wang X, Jeyamohan C, Wang L, Zhu L, Santucci-Pereira J, Greenawalt DM, Tabernero J. Luke JJ, et al. Among authors: desai j. Clin Cancer Res. 2024 Dec 13. doi: 10.1158/1078-0432.CCR-24-0439. Online ahead of print. Clin Cancer Res. 2024. PMID: 39670852
Holistic approaches to living well with endometriosis.
Desai J, Strong S, Ball E. Desai J, et al. F1000Res. 2024 Nov 8;13:359. doi: 10.12688/f1000research.142586.2. eCollection 2024. F1000Res. 2024. PMID: 39649833 Free PMC article. Review.
932 results